ESC Premium Access

Liraglutide and empagliflozin – An evaluation of benefits.

Congress Presentation

About the speaker

Associate Professor Thomas Andersen Schmidt

Bispebjerg University Hospital, Copenhagen (Denmark)
1 presentation
0 follower

3 more presentations in this session

Treatment aims of glucose lowering drugs in patients with type 2 diabetes

Speaker: Professor L. Ryden (Stockholm, SE)

Thumbnail

Rethinking the appraisal and approval of drugs for type 2 diabetes.

Speaker: Professor A. Tsapas (Thessaloniki, GR)

Thumbnail

Is type 2 diabetes a category error - How about treating the elderly?

Speaker: Professor G. Schernthaner (Vienna, AT)

Thumbnail

Access the full session

Treatment of type 2 diabetes - Important new aspects for the cardiologist

Speakers: Associate Professor T. Schmidt, Professor L. Ryden, Professor A. Tsapas, Professor G. Schernthaner
Thumbnail

About the event

Image

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb